Please login to the form below

Not currently logged in


This page shows the latest CTCL news and features for those working in and with pharma, biotech and healthcare.

Almirall eyes $62m takeover of multicytokine specialist Bioniz

Almirall eyes $62m takeover of multicytokine specialist Bioniz

for cutaneous T-cell lymphoma (CTCL). ... BNZ-1 a selective and simultaneous inhibitor of cytokines IL-2, IL-9 and IL-15 which is in early-stage testing for CTCL and also has potential for alopecia areata,

Latest news

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Integrating patient reported outcomes into clinical trials Integrating patient reported outcomes into clinical trials

    Takeda, for example, used EQ- 5D in its Adcetris programme despite doubts about whether the measure was sensitive enough to show the therapy’s effect on cutaneous T-cell lymphoma (CTCL) ... However, those and other limitations are unlikely to last

  • Pharma deals in August 2015 Pharma deals in August 2015

    30600. Therakos. Mallinckrodt. Approved cell therapy platform for the palliative treatment of cutaneous T‐cell lymphoma [CTCL].

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    387. Ceptaris Therapeutics / Actelion. Acquisition. Valchlor for mycosis fungoides-type CTCL (NDA). ... CTCL = cutaneous T-cell lymphoma. VLP  = virus-like particle produced in plant expression systems .

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...